Top 10 — Real Estate — 1 Sep 2026

Valuation 83rd (price to earnings 17.8, price to book 1.6) and financial health 82nd (free cash flow margin 31.5%, debt to equity 0.2); weakest is capital return (51st, net share count bought back over the year -7.2, consecutive years of dividend increases 5 years).

• Profitability65.2
• Growth78.0
• Financial health82.1
• Valuation82.5
• Capital return50.8
• Trend54.8

Growth 94th (revenue growth year over year 53%, 3-year revenue CAGR 34.4%) and financial health 71st (debt to equity 0.3); weakest is capital return (42nd, net share count bought back over the year -31.5, consecutive years of dividend increases 5 years).

• Profitability67.4
• Growth94.3
• Financial health70.6
• Valuation65.3
• Capital return41.7
• Trend60.4

Profitability 78th (operating margin 46.1%, return on equity 16.5%) and valuation 73rd (price to earnings 17.1, price to book 2.6); weakest is capital return (47th, net share count bought back over the year -12.8, consecutive years of dividend increases 5 years).

• Profitability78.4
• Growth65.9
• Financial health69.6
• Valuation73.4
• Capital return46.5
• Trend51.3

Valuation 85th (price to earnings 15.1, price to book 1.8) and growth 74th (3-year revenue CAGR 14.5%); weakest is financial health (51st, debt to equity 0.6).

• Profitability52.7
• Growth74.2
• Financial health50.8
• Valuation84.7
• Capital return53.2
• Trend70.6

Growth 87th (3-year revenue CAGR 26.7%, revenue growth year over year 28.4%) and capital return 80th (consecutive years of dividend increases 5 years); weakest is valuation (42nd, price to book 4.8, price to earnings 30.4).

• Profitability71.6
• Growth86.5
• Financial health69.9
• Valuation41.6
• Capital return80.2
• Trend43.2

Profitability 97th (return on equity 126.3%, operating margin 48.3%) and capital return 67th (consecutive years of dividend increases 5 years, net share count bought back over the year -0.1); weakest is financial health (52nd, debt to equity 5.8, free cash flow margin 48.6%).

• Profitability96.9
• Growth52.5
• Financial health51.6
• Valuation53.0
• Capital return67.2
• Trend55.6

Valuation 98th (price to earnings 9.9, price to book 1) and financial health 74th (free cash flow margin 49.7%, debt to equity 0.6); weakest is trend (25th, a "death cross" — its 50-day average is below its 200-day).

• Profitability69.8
• Growth52.8
• Financial health74.4
• Valuation97.5
• Capital return60.6
• Trend25.3

Profitability 73rd (operating margin 41.6%, return on equity 13.4%) and capital return 68th (consecutive years of dividend increases 5 years, net share count bought back over the year -0.1); weakest is financial health (37th, debt to equity 0.9).

• Profitability72.7
• Growth55.3
• Financial health37.3
• Valuation64.4
• Capital return67.6
• Trend61.3

Valuation 80th (price to earnings 19.1, price to book 1.8) and profitability 68th (operating margin 58.5%, return on equity 9.3%); weakest is financial health (36th, debt to equity 1).

• Profitability68.0
• Growth60.4
• Financial health35.6
• Valuation79.9
• Capital return55.9
• Trend51.2

Growth 78th (3-year revenue CAGR 18.7%, revenue growth year over year 18.2%) and profitability 59th (operating margin 47.9%, return on equity 3.6%); weakest is trend (40th, a strong downtrend, with sellers in control).

• Profitability59.4
• Growth77.6
• Financial health52.2
• Valuation58.7
• Capital return49.4
• Trend40.4